Frontlight ResearchEarly access
Trial site
Hangzhou Cancer Hospital
- 4running trials
- 5closed trials
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Lung cancer4 trials
- Metastatic breast cancer2 trials
- Colorectal cancer1 trial
- Gastric and oesophageal cancer1 trial
- Ovarian cancer1 trial
- Pancreatic cancer1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 37 trials
- Phase 1/21 trial
- Phase 21 trial
- Status
- Completed4 trials
- Not yet recruiting2 trials
- Active, not recruiting1 trial
- Recruiting1 trial
- Terminated1 trial
- Lead sponsor
- BeiGene1 trial
- Bing Xia1 trial
- Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.1 trial
- Genor Biopharma Co., Ltd.1 trial
- Hoffmann-La Roche1 trial
- and 4 more
Running trials
Not yet recruiting
Recruiting
Recruiting
Active, not recruiting
Adjuvant Treatment of EC Followed by Taxane +/- Carboplatin in Triple-Negative Breast Cancer
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Metastatic breast cancer2 recruiting
- Colorectal cancer1 recruiting
- Lung cancer1 recruiting
- Pancreatic cancer1 recruiting
Closed trials
Terminated
AP-L1898 Capsule in Patients With Non-small Cell Lung Cancer
Completed
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026